Amgen's Repatha Is Too Bloody Pricey for the U.K.
November 19 2015 - 10:03AM
The Motley Fool
http://www.fool.com/investing/general/2015/11/19/amgens-repatha-is-too-bloody-pricey-for-the-uk.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Sep 2023 to Sep 2024
